How ancient is temporal arteritis?, J Rheumatol, vol.17, issue.7, pp.929-960, 1990. ,
The Early History of Giant Cell Arteritis and Polymyalgia Rheumatica: First Descriptions to 1970, Mayo Clinic Proceedings, vol.81, issue.8, pp.1071-1083, 2006. ,
DOI : 10.4065/81.8.1071
Epidemiologic approach to Horton's disease in the department of Loire-Atlantique. 110 cases in 10 years (1970-1979)]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, mars, vol.3, issue.1, pp.13-20, 1982. ,
Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, Can J Ophthalmol J Can Ophtalmol. avr, vol.42, issue.2, pp.295-298, 1998. ,
The epidemiology of giant cell arteritis. Report of a Ten-Year Study in Shelby County, Tennessee, Arthritis & Rheumatism, vol.20, issue.10, pp.1214-1219, 1983. ,
DOI : 10.1002/art.1780261007
Temporal Arteritis, Scottish Medical Journal, vol.185, issue.2, pp.111-117, 1979. ,
DOI : 10.1177/003693307902400203
GIANT CELL ARTERITIS IN JERUSALEM: A 12-YEAR EPIDEMIOLOGICAL STUDY, Rheumatology, vol.33, issue.10, pp.938-941, 1994. ,
DOI : 10.1093/rheumatology/33.10.938
Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: The first government-supported nationwide survey, Arthritis & Rheumatism, vol.39, issue.4, pp.594-602, 2003. ,
DOI : 10.1002/art.11195
Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings, J Rheumatol. nov, vol.27, issue.11, pp.2624-2627, 2000. ,
Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection, J Rheumatol. janv, vol.23, issue.1, pp.112-119, 1996. ,
Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a danish county, Arthritis & Rheumatism, vol.103, issue.3, pp.294-299, 1987. ,
DOI : 10.1002/art.1780300308
Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988, J Rheumatol. févr, vol.19, issue.2, pp.273-276, 1992. ,
Giant cell arteritis in Iceland., Arthritis & Rheumatism, vol.34, issue.7, pp.1007-1012, 1994. ,
DOI : 10.1002/art.1780370705
Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden, Scandinavian Journal of Rheumatology, vol.11, issue.5, pp.487-497, 2013. ,
DOI : 10.1186/1471-2377-12-41
Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period, Arthritis Care & Research, vol.29, issue.2, pp.264-268, 2004. ,
DOI : 10.1002/art.20227
Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy, Arthritis & Rheumatism, vol.28, issue.3, pp.351-356, 1991. ,
DOI : 10.1002/art.1780340313
Giant Cell Arteritis in Northwestern Spain, Medicine, vol.86, issue.2, pp.61-68, 2007. ,
DOI : 10.1097/md.0b013e31803d1764
10-year epidemiological study on rheumatic diseases in Shantou area], Zhonghua Nei Ke Za Zhi. mars, vol.36, issue.3, pp.193-197, 1997. ,
Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations, J Rheumatol. août, vol.21, issue.8, pp.1484-1490, 1994. ,
Epidemiology of large-vessel vasculidities, Best Practice & Research Clinical Rheumatology, vol.24, issue.6, pp.871-883, 2010. ,
DOI : 10.1016/j.berh.2010.10.008
Giant cell (temporal) arteritis in Singapore: an occult case and the rationale of treatment, Singapore Med J. janv, vol.51, issue.1, pp.73-77, 2010. ,
Epidemiology of giant-cell arteritis in an Arab population: a 22-year study, British Journal of Ophthalmology, vol.91, issue.6, pp.715-718, 2007. ,
DOI : 10.1136/bjo.2006.108845
Giant cell arteritis in Asians: a comparative study, British Journal of Ophthalmology, vol.95, issue.2, pp.214-216, 2011. ,
DOI : 10.1136/bjo.2009.177220
The epidemiology of giant cell arteritis, Ophthalmology, vol.108, issue.6, pp.1145-1149, 2001. ,
DOI : 10.1016/S0161-6420(01)00574-7
Epid??miologie, imagerie et traitement de la maladie de Horton, Revue du Rhumatisme, vol.75, issue.5, pp.392-397, 2008. ,
DOI : 10.1016/j.rhum.2007.09.008
Epidemiological and clinical features of giant cell arteritis in Tunisia, European Journal of Internal Medicine, vol.20, issue.2, pp.208-212, 2009. ,
DOI : 10.1016/j.ejim.2008.07.030
The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations, Clin Exp Rheumatol. févr, vol.25, issue.1, pp.15-17, 2007. ,
Physiopathologie de l???art??rite ?? cellules g??antes, La Revue de M??decine Interne, vol.34, issue.7 ,
DOI : 10.1016/j.revmed.2013.02.037
The Geo-epidemiology of Temporal (Giant Cell) Arteritis, Clinical Reviews in Allergy & Immunology, vol.65, issue.1-2, pp.88-95, 2008. ,
DOI : 10.1007/s12016-008-8075-0
Classification des vascularites syst??miques, La Presse M??dicale, vol.41, issue.10, pp.986-995, 2012. ,
DOI : 10.1016/j.lpm.2012.06.006
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis & Rheumatism, vol.33, issue.8, pp.1122-1128, 1990. ,
DOI : 10.1002/art.1780330810
Maladie de Horton et pseudopolyarthrite rhizomélique : critères diagnostiques. Rev Médecine Interne [Internet]. [cité 21 juin 2013]; Disponible sur: http://www.sciencedirect.com/science ,
DOI : 10.1016/j.revmed.2013.02.025
Incidence des??accidents cardiovasculaires au??cours de??la??maladie de??Horton??: r??sultats pr??liminaires de??l'??tude prospective en??double cohorte GRACG, La Revue de M??decine Interne, vol.27, issue.2, pp.98-105, 2006. ,
DOI : 10.1016/j.revmed.2005.10.009
Polymyalgia Rheumatica and Giant-Cell Arteritis, New England Journal of Medicine, vol.347, issue.4, pp.261-271, 2002. ,
DOI : 10.1056/NEJMra011913
Giant Cell Arteritis (Temporal Arteritis) Presenting as Fever of Undetermined Origin, Arthritis & Rheumatism, vol.52, issue.11, pp.1414-1418, 1981. ,
DOI : 10.1002/art.1780241113
Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis, Arthritis & Rheumatism, vol.94, issue.6, pp.1259-1266, 1999. ,
DOI : 10.1002/1529-0131(199906)42:6<1259::AID-ANR24>3.0.CO;2-I
Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment, Arthritis & Rheumatism, vol.40, issue.8, pp.1497-1504, 1998. ,
DOI : 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z
Neurologic disease in biopsy-proven giant cell (temporal) arteritis, Neurology, vol.38, issue.3, pp.352-359, 1988. ,
DOI : 10.1212/WNL.38.3.352
Respiratory Tract Symptoms as a Clue to Giant Cell Arteritis, Annals of Internal Medicine, vol.101, issue.5, pp.594-597, 1984. ,
DOI : 10.7326/0003-4819-101-5-594
Bilateral vertebral artery occlusion with retrograde basilary flow in three cases of giant cell arteritis, Case Reports, vol.2009, issue.feb24 1, 2009. ,
DOI : 10.1136/bcr.07.2008.0488
Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein for the Diagnosis of Giant Cell Arteritis, Seminars in Arthritis and Rheumatism, vol.41, issue.6, pp.866-871, 2012. ,
DOI : 10.1016/j.semarthrit.2011.10.005
Anticardiolipin antibodies and giant cell arteritis: A prospective, multicenter case-control study, Arthritis & Rheumatism, vol.332, issue.4, pp.701-709, 1998. ,
DOI : 10.1002/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P
Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases, Rheumatology, vol.39, issue.10, pp.1089-1094, 2000. ,
DOI : 10.1093/rheumatology/39.10.1089
Absence of anti-beta2 glycoprotein I antibodies in giant cell arteritis: a study of 45 biopsy-proven cases, Rheumatology, vol.37, issue.10, pp.1129-1131, 1998. ,
DOI : 10.1093/rheumatology/37.10.1129
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica, Annals of the Rheumatic Diseases, vol.71, issue.6, pp.943-947, 2012. ,
DOI : 10.1136/annrheumdis-2011-200413
Quelle place pour le dosage des anticorps anti-ferritine au cours de l'artérite à cellules géantes ? Rev Médecine Interne, déc, vol.33, issue.2, p.54, 2012. ,
Color Duplex Ultrasonography in the Diagnosis of Temporal Arteritis, New England Journal of Medicine, vol.337, issue.19, pp.1336-1342, 1997. ,
DOI : 10.1056/NEJM199711063371902
Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis, Annals of Internal Medicine, vol.142, issue.5, pp.359-369, 2005. ,
DOI : 10.7326/0003-4819-142-5-200503010-00011
Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis, Arthritis Research & Therapy, vol.8, issue.4, p.116, 2006. ,
DOI : 10.1186/ar2003
Performance diagnostique de nouveaux crit??res ??chographiques dans la maladie de Horton??: mesure de l?????paississement temporal et rapport ?? l?????paisseur intima-media carotidienne, La Revue de M??decine Interne, vol.34, p.75, 2013. ,
DOI : 10.1016/j.revmed.2013.10.115
??valuation des performances de l?????chographie-doppler des art??res temporales pour le diagnostic de maladie de horton. ?? propos de 39 examens, Journal des Maladies Vasculaires, vol.31, issue.4, p.29, 2006. ,
DOI : 10.1016/S0398-0499(06)76598-2
Diagnostic Value of High-Resolution MR Imaging in Giant Cell Arteritis, American Journal of Neuroradiology, vol.28, issue.9, pp.1722-1727, 2007. ,
DOI : 10.3174/ajnr.A0638
Influence of corticosteroid treatment on MRI findings in giant cell arteritis, Clinical Rheumatology, vol.65, issue.2, pp.1541-1543, 2007. ,
DOI : 10.1007/s10067-006-0427-7
New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography, Rheumatology, vol.38, issue.5, pp.444-447, 1999. ,
DOI : 10.1093/rheumatology/38.5.444
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.11, pp.1764-1772, 2011. ,
DOI : 10.1007/s00259-011-1830-0
Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review, Clinical Rheumatology, vol.50, issue.3 Suppl 49, pp.1265-1275, 2011. ,
DOI : 10.1007/s10067-011-1828-9
Place de la tomographie par ??mission de positons (TEP) au [18F]FDG dans l???exploration des vascularites, M??decine Nucl??aire, vol.32, issue.10, pp.511-522, 2008. ,
DOI : 10.1016/j.mednuc.2008.07.003
A Bayesian Analysis of the True Sensitivity of a Temporal Artery Biopsy, Investigative Opthalmology & Visual Science, vol.48, issue.2, pp.675-680, 2007. ,
DOI : 10.1167/iovs.06-1106
Temporal artery biopsy for giant cell arteritis: retrospective audit Disponible sur, JRSM Short Rep [Internet], vol.223, issue.10 ,
DOI : 10.1258/shorts.2012.012069
URL : http://doi.org/10.1258/shorts.2012.012069
Effect of biopsy length on the rate of positive temporal artery biopsies, Clin Exp Rheumatol. févr, vol.27, issue.1, pp.10-13, 2009. ,
Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?, Annals of the Rheumatic Diseases, vol.65, issue.6, pp.826-828, 2006. ,
DOI : 10.1136/ard.2005.042770
Importance of specimen length during temporal artery biopsy, British Journal of Surgery, vol.56, issue.Suppl 52, pp.1556-1560, 2011. ,
DOI : 10.1002/bjs.7595
Les vascularites n??crosantes syst??miques??: classification et strat??gies actuelles de traitement, La Revue de M??decine Interne, vol.24, issue.3, pp.172-182, 2003. ,
DOI : 10.1016/S0248-8663(02)00815-9
HLA-DRB1*04 may be a marker of severity in giant cell arteritis, Annals of the Rheumatic Diseases, vol.59, issue.7, pp.574-575, 2000. ,
DOI : 10.1136/ard.59.7.574a
Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes, Rheumatology, vol.51, issue.5, pp.841-851, 2012. ,
DOI : 10.1093/rheumatology/ker429
Dendritic cells and cytokines in human inflammatory and autoimmune diseases, Cytokine & Growth Factor Reviews, vol.19, issue.1, pp.41-52, 2008. ,
DOI : 10.1016/j.cytogfr.2007.10.004
URL : https://hal.archives-ouvertes.fr/hal-00275657
Vessel-Specific Toll-Like Receptor Profiles in Human Medium and Large Arteries, Circulation, vol.118, issue.12, pp.1276-1284, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.108.789172
Toll-Like Receptors 4 and 5 Induce Distinct Types of Vasculitis, Circulation Research, vol.104, issue.4, pp.488-495, 2009. ,
DOI : 10.1161/CIRCRESAHA.108.185777
Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis, The Journal of Experimental Medicine, vol.42, issue.2, pp.173-183, 2004. ,
DOI : 10.1002/art.10071
Trapping of Misdirected Dendritic Cells in the Granulomatous Lesions of Giant Cell Arteritis, The American Journal of Pathology, vol.161, issue.5 ,
DOI : 10.1016/S0002-9440(10)64458-6
Giant cell vasculitis is a T cell-dependent disease, Mol Med Camb Mass. août, vol.3, issue.8, pp.530-543, 1997. ,
Th17 and Th1 T-Cell Responses in Giant Cell Arteritis, Circulation, vol.121, issue.7, pp.906-915, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.109.872903
Therapeutic effects of acetylsalicylic acid in giant cell arteritis, Arthritis & Rheumatism, vol.134, issue.2, pp.457-66, 2002. ,
DOI : 10.1002/art.10071
Pathog??nie de l???art??rite ?? cellules g??antes, La Presse M??dicale, vol.41, issue.10, pp.937-947, 2012. ,
DOI : 10.1016/j.lpm.2012.07.005
Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica, Clinical & Experimental Immunology, vol.380, issue.2, pp.379-85, 2002. ,
DOI : 10.1046/j.1365-2249.2002.01751.x
Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach, Arthritis Research & Therapy, vol.13, issue.3, p.107, 2011. ,
DOI : 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis., Journal of Clinical Investigation, vol.98, issue.7, pp.1642-1649, 1996. ,
DOI : 10.1172/JCI118959
Metalloproteinase-2 and -9 in Giant Cell Arteritis: Involvement in Vascular Remodeling, Circulation, vol.112, issue.2, pp.264-269, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.104.520114
Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis, Journal of Clinical Investigation, vol.103, issue.7, pp.1007-1013, 1999. ,
DOI : 10.1172/JCI4711
Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis, Arthritis & Rheumatism, vol.96, issue.4, pp.623-633, 1998. ,
DOI : 10.1002/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6
Formation of New Vasa Vasorum in Vasculitis, The American Journal of Pathology, vol.155, issue.3, pp.765-774, 1999. ,
DOI : 10.1016/S0002-9440(10)65175-9
Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: Inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions, Arthritis & Rheumatism, vol.333, issue.1, pp.184-194, 2000. ,
DOI : 10.1002/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N
Tissue and Serum Angiogenic Activity Is Associated With Low Prevalence of Ischemic Complications in Patients With Giant-Cell Arteritis, Circulation, vol.106, issue.13, pp.1664-1671, 2002. ,
DOI : 10.1161/01.CIR.0000030185.67510.C0
Tissue production of pro-inflammatory cytokines (IL-1??, TNF?? and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis, Rheumatology, vol.43, issue.3, pp.294-301, 2004. ,
DOI : 10.1093/rheumatology/keh058
Maladie de Horton et pseudopolyarthrite rhizom??lique??: nouveaut??s th??rapeutiques??? ??volution et pronostic, La Revue de M??decine Interne, vol.29, pp.281-285, 2008. ,
DOI : 10.1016/j.revmed.2008.10.008
Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden, J Rheumatol. avr, vol.29, issue.4, pp.737-742, 2002. ,
Excess mortality in giant cell arteritis, Journal of Internal Medicine, vol.299, issue.Suppl. 658, pp.119-123, 1991. ,
DOI : 10.1111/j.1365-2796.1991.tb00418.x
Giant Cell Arteritis and Mortality, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.64, issue.3, pp.365-369, 2009. ,
DOI : 10.1093/gerona/gln030
Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients, J Rheumatol. juill, vol.21, issue.7, pp.1283-1286, 1994. ,
Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy., BMJ, vol.299, issue.6698, pp.549-550, 1989. ,
DOI : 10.1136/bmj.299.6698.549
Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls, Rheumatology, vol.40, issue.11, pp.1238-1242, 2001. ,
DOI : 10.1093/rheumatology/40.11.1238
Causes de mortalit?? dans la maladie de Horton et la pseudopolyarthrite rhizom??lique??: ??tude prospective en double cohorte GRACG, La Revue de M??decine Interne, vol.29, pp.324-325, 2008. ,
DOI : 10.1016/j.revmed.2008.10.102
EULAR recommendations for the management of large vessel vasculitis, Annals of the Rheumatic Diseases, vol.68, issue.3, pp.318-323, 2009. ,
DOI : 10.1136/ard.2008.088351
Giant Cell Arteritis: Oral Versus Intravenous Corticosteroids, Neuro-Ophthalmology, vol.31, issue.6, pp.1-15, 2009. ,
DOI : 10.1080/01658100802716754
Management of Giant Cell Arteritis, Ophthalmologica, vol.217, issue.4, pp.239-259, 2003. ,
DOI : 10.1159/000070631
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial, Arthritis & Rheumatism, vol.43, issue.10, pp.3310-3318, 2006. ,
DOI : 10.1002/art.22163
Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis, Arthritis & Rheumatism, vol.37, issue.8, pp.2789-2797, 2007. ,
DOI : 10.1002/art.22754
Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review, Seminars in Arthritis and Rheumatism, vol.43, issue.1, pp.105-112, 2013. ,
DOI : 10.1016/j.semarthrit.2012.12.023
Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study., Annals of the Rheumatic Diseases, vol.45, issue.2, pp.136-138, 1986. ,
DOI : 10.1136/ard.45.2.136
Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis, Annals of Internal Medicine, vol.146, issue.9, pp.621-630, 2007. ,
DOI : 10.7326/0003-4819-146-9-200705010-00004
Infliximab plus Prednisone or Placebo plus Prednisone for the Initial Treatment of Polymyalgia Rheumatica, Annals of Internal Medicine, vol.146, issue.9, pp.631-639, 2007. ,
DOI : 10.7326/0003-4819-146-9-200705010-00005
Tocilizumab in glucocorticoid-naïve large-vessel vasculitis, Clin Exp Rheumatol. févr, vol.31, issue.1, pp.59-61, 2013. ,
Interleukin-1 blockade in refractory giant cell arteritis, Joint Bone Spine, vol.81, issue.1, 2013. ,
DOI : 10.1016/j.jbspin.2013.06.004
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis, Disponible sur, 2014. ,
DOI : 10.1016/j.semarthrit.2013.10.009
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis, Arthritis & Rheumatism, vol.41, issue.10, pp.3306-3309, 2006. ,
DOI : 10.1002/art.22141
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis, Rheumatology, vol.48, issue.3, pp.250-253, 2009. ,
DOI : 10.1093/rheumatology/ken465
Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis, Medicine, vol.88, issue.4, pp.227-235, 2009. ,
DOI : 10.1097/MD.0b013e3181af4518
Risk Factors for Cranial Ischemic Complications in Giant Cell Arteritis, Medicine, vol.83, issue.2, pp.114-122, 2004. ,
DOI : 10.1097/01.md.0000119761.27564.c9
URL : http://doi.org/10.1097/01.md.0000119761.27564.c9
Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis, Rheumatology International, vol.42, issue.Suppl 36 ,
DOI : 10.1007/s00296-013-2814-0
Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors, Rheumatology, vol.50, issue.11, pp.2014-2022, 2011. ,
DOI : 10.1093/rheumatology/ker265
Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis, Medicine, vol.87, issue.6, pp.335-344, 2008. ,
DOI : 10.1097/MD.0b013e3181908e96
Giant cell arteritis as a cause of death. Report of nine cases, JAMA: The Journal of the American Medical Association, vol.255, issue.4, pp.493-496, 1986. ,
DOI : 10.1001/jama.255.4.493
Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis, Medicine, vol.82, issue.1, pp.1-12, 2003. ,
DOI : 10.1097/00005792-200301000-00001
Giant cell arteritis: Involvement of intracranial arteries, Arthritis & Rheumatism, vol.48, issue.6, pp.985-989, 2006. ,
DOI : 10.1002/art.22359
Microanatomie de la traversée durale de l'artère vertébrale, Rev Int Sci Médicales, vol.8, issue.3, pp.39-43, 2006. ,
Arteries of the Head and Neck in Giant Cell Arteritis, Archives of Neurology, vol.27, issue.5, pp.378-391, 1972. ,
DOI : 10.1001/archneur.1972.00490170010003
Fatal vertebral giant cell arteritis., Journal of Clinical Pathology, vol.46, issue.12, pp.1129-1131, 1993. ,
DOI : 10.1136/jcp.46.12.1129
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC501727/pdf
Pattern of arterial involvement of the head, neck, and eyes in giant cell arteritis: three case reports., British Journal of Ophthalmology, vol.75, issue.6, pp.368-371, 1991. ,
DOI : 10.1136/bjo.75.6.368
Bilateral vertebral artery occlusion in giant cell arteritis, Clin Exp Rheumatol. avr, vol.24, issue.2, p.101, 2006. ,
Angioplastie carotidienne bilat??rale chez une patiente avec infarctus c??r??bral sur maladie de Horton, Revue Neurologique, vol.166, issue.3, pp.328-332, 2010. ,
DOI : 10.1016/j.neurol.2009.05.011
Vertebral arteries: A target for FDG-PET imaging in giant cell arteritis?, Nuklearmedizin, vol.50, issue.1, pp.28-32, 2011. ,
DOI : 10.3413/nukmed-0335-10-07
Internal carotid artery occlusion caused by giant cell arteritis., Journal of Neurology, Neurosurgery & Psychiatry, vol.42, issue.11, pp.1066-1067, 1979. ,
DOI : 10.1136/jnnp.42.11.1066
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC490404/pdf
Bilateral carotid artery occlusion resulting from giant cell arteritis, Annals of Neurology, vol.27, issue.2, pp.204-211, 1984. ,
DOI : 10.1002/ana.410150216
Systemic giant cell arteritis and cerebellar infarction, Stroke, vol.24, issue.6, pp.899-902, 1993. ,
DOI : 10.1161/01.STR.24.6.899
Disease patterns and tissue cytokine profiles in giant cell arteritis, Arthritis & Rheumatism, vol.81, issue.1, pp.19-26, 1997. ,
DOI : 10.1002/art.1780400105
Elevated Production of Interleukin-6 Is Associated With a Lower Incidence of Disease-Related Ischemic Events in Patients With Giant-Cell Arteritis Angiogenic Activity of Interleukin-6 as a Potential Protective Mechanism. Circulation, pp.2428-2434, 2003. ,
A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis, J Rheumatol. sept, vol.32, issue.9, pp.1737-1741, 2005. ,
Predictors of cerebrovascular accidents in giant cell arteritis in a defined population ,
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis, Arthritis & Rheumatism, vol.20, issue.4, pp.1332-1337, 2004. ,
DOI : 10.1002/art.20171
Translational Mini-Review Series on Immunology of Vascular Disease: Accelerated atherosclerosis in vasculitis, Clinical & Experimental Immunology, vol.34, issue.2, pp.377-385, 2009. ,
DOI : 10.1111/j.1365-2249.2009.03885.x
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis, Arthritis & Rheumatism, vol.31, issue.1, pp.26-32, 1998. ,
DOI : 10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0
Giant Cell Arteritis, Medicine, vol.84, issue.5, pp.277-290, 2005. ,
DOI : 10.1097/01.md.0000180043.19285.54
Accident vasculaire cérébral : prise en charge précoce (alerte, phase préhospitalière, phase hospitalière initiale, indications de la thrombolyse) [Internet]. [cité 23 déc 2013]. Disponible sur: http://www.hassante.fr/portail/jcms/c_830203/fr/accident-vasculaire-cerebral-prise-en-charge-precoce- alerte-phase-prehospitaliere-phase-hospitaliere-initiale-indications-de-la- thrombolyse?xtmc=&xtcr=5 ,
Giant cell (temporal) arteritis: A treatable cause of multi-infarct dementia, Neurology, vol.40, issue.5, pp.753-755, 1990. ,
DOI : 10.1212/WNL.40.5.753
Confused by arteritis. The Lancet, janv, vol.355, issue.9201, pp.374-375, 2000. ,
DOI : 10.1016/s0140-6736(99)11011-0
Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica--an ultrasonographic case-control study, J Rheumatol. déc, vol.32, issue.12, pp.2356-2360, 2005. ,
Vertebral Artery Halo Sign in Patients With Stroke: A Key Clue for the Prompt Diagnosis of Giant Cell Arteritis, Stroke, vol.42, issue.11 ,
DOI : 10.1161/STROKEAHA.111.625152
Involvement of the vertebral arteries in giant cell arteritis mimicking vertebral dissection, J Neurol. 1 août, vol.250, issue.8, pp.1006-1009, 2003. ,
Spiral computed tomographic angiography in the diagnosis of vertebral artery occlusive lesions], Vestn Rentgenol Radiol. oct, issue.5, pp.21-24, 2007. ,
Noninvasive Detection of Vertebral Artery Stenosis, Stroke, vol.40, issue.11, pp.3499-3503, 2009. ,
DOI : 10.1161/STROKEAHA.109.556035
Quand, comment et pourquoi r??aliser une imagerie des carotides extracr??niennes ?, Journal de Radiologie, vol.85, issue.6, pp.825-844, 2004. ,
DOI : 10.1016/S0221-0363(04)97689-5
Extracranial angiographic findings in giant cell (temporal) arteritis, American Journal of Roentgenology, vol.127, issue.6, pp.957-963, 1976. ,
DOI : 10.2214/ajr.127.6.957
High resolution 3T MRI for the assessment of cervical and superficial cranial arteries in giant cell arteritis, Journal of Magnetic Resonance Imaging, vol.18, issue.2 ,
DOI : 10.1002/jmri.20639
Two ischemic cerebral accidents in treated Horton disease: caused by adrenal cortex hormone therapy?]. Presse Médicale Paris Fr 1983. 5 mars, p.449, 1994. ,
Deterioration of Giant Cell Arteritis With Corticosteroid Therapy, Archives of Neurology, vol.57, issue.4, pp.581-584, 2000. ,
DOI : 10.1001/archneur.57.4.581
Multiple strokes after initiation of steroid therapy in giant cell arteritis., Postgraduate Medical Journal, vol.70, issue.821, pp.228-230, 1994. ,
DOI : 10.1136/pgmj.70.821.228
Angioplasty and stent placement for complete occlusion of the vertebral artery secondary to giant cell arteritis, Journal of NeuroInterventional Surgery, vol.4, issue.2, pp.110-113, 2012. ,
DOI : 10.1136/jnis.2011.004689
Two Cases of Recurrent Stroke in Treated Giant Cell Arteritis, JCR: Journal of Clinical Rheumatology, vol.16, issue.5, pp.225-228, 2010. ,
DOI : 10.1097/RHU.0b013e3181e9a338
Insidious posterior circulation stroke with rapid deterioration due to vertebral giant cell arteritis, Age and Ageing, vol.36, issue.6, pp.695-697, 2007. ,
DOI : 10.1093/ageing/afm136
URL : http://ageing.oxfordjournals.org/cgi/content/short/36/6/695
R??gression de st??noses intracr??niennes vert??brobasilaires symptomatiques sous corticoth??rapie au cours d???une maladie de Horton, Revue Neurologique, vol.166, issue.11, pp.940-943, 2010. ,
DOI : 10.1016/j.neurol.2010.03.007
Vertebrobasilar Infarction Related to Giant Cell (Temporal) Arteritis: Case Report, Neurologia medico-chirurgica, vol.55, issue.1, pp.27-2013 ,
DOI : 10.2176/nmc.cr.2013-0038
Temporal Arteritis with Cerebral Complications: Report of Four Cases, European Neurology, vol.34, issue.3, pp.162-167, 1994. ,
DOI : 10.1159/000117031
Glucocorticoids in the management of vasculitis--a double edged sword?, J Rheumatol. août, vol.15, issue.8, pp.1181-1183, 1988. ,
Accidents vasculaires enc??phaliques pr??coces apr??s instauration d'une corticoth??rapie au cours de la maladie de Horton, La Revue de M??decine Interne, vol.21, issue.6, pp.550-554, 2000. ,
DOI : 10.1016/S0248-8663(00)89232-2
Therapeutic approach to giant cell arteritis, Joint Bone Spine, vol.79, issue.3, pp.219-227, 2012. ,
DOI : 10.1016/j.jbspin.2011.09.015
G - 2 St??nose vert??bro-basilaire r??versible sous cortico??des et anticoagulant au cours d???une maladie de Horton, Revue Neurologique, vol.163, issue.4, p.11, 2007. ,
DOI : 10.1016/S0035-3787(07)90508-1
Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events, Archives of Internal Medicine, vol.162, issue.19, pp.2197-2202, 2002. ,
DOI : 10.1001/archinte.162.19.2197
Corticotherapie generale, Rev Prat Med Gen, issue.830, pp.741-786, 2009. ,
Review: Diagnosis and treatment of cerebral vasculitis, Therapeutic Advances in Neurological Disorders, vol.322, issue.1, pp.29-42, 2010. ,
DOI : 10.1177/1756285609347123
Lethal giant cell arteritis with multiple ischemic strokes despite aggressive immunosuppressive therapy, Journal of the Neurological Sciences, vol.295, issue.1-2, pp.120-124, 2010. ,
DOI : 10.1016/j.jns.2010.05.008
Maladie de Horton d?????volution fatale avec atteinte s??v??re bilat??rale des art??res vert??brales, Revue Neurologique, vol.162, issue.8-9, pp.8-9876, 2006. ,
DOI : 10.1016/S0035-3787(06)75095-0
Accident vasculaire c??r??bral isch??mique ,
DOI : 10.1016/B978-2-8101-0122-1.00003-0
Syndrome inflammatoire chez la personne ??g??e, EMC - M??decine, vol.2, issue.3, pp.284-290, 2005. ,
DOI : 10.1016/j.emcmed.2004.12.003
Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease, Annals of the Rheumatic Diseases, vol.58, issue.6, pp.335-341, 1999. ,
DOI : 10.1136/ard.58.6.335
Biopsy-negative giant cell arteritis: Clinical spectrum and predictive factors for positive temporal artery biopsy, Seminars in Arthritis and Rheumatism, vol.30, issue.4, pp.249-256, 2001. ,
DOI : 10.1053/sarh.2001.16650
Giant Cell Arteritis Revealed by Vertebrobasilar Insufficiency, The Journal of Rheumatology, vol.36, issue.2, pp.457-458, 2009. ,
DOI : 10.3899/jrheum.080922
Les vascularites du syst??me nerveux central??: mise au point, La Revue de M??decine Interne, vol.33, issue.7, pp.381-389, 2012. ,
DOI : 10.1016/j.revmed.2011.11.020
Role of oral cyclophosphamide in the treatment of giant cell arteritis, Rheumatology, vol.51, issue.9 ,
DOI : 10.1093/rheumatology/kes127
Traitement de la maladie de Horton, La Revue de M??decine Interne, vol.34, issue.7, pp.431-437, 2013. ,
DOI : 10.1016/j.revmed.2013.02.032
Complications de la corticoth??rapie chez les patients souffrant de maladie de Horton ou de pseudopolyarthrite rhizom??lique, La Revue de M??decine Interne, vol.34, issue.7, pp.438-443, 2013. ,
DOI : 10.1016/j.revmed.2013.02.031
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases, Annals of the Rheumatic Diseases, vol.66, issue.12, pp.1560-1567, 2007. ,
DOI : 10.1136/ard.2007.072157
has-sante.fr/portail/jcms/c_437005/fr/prise-en-charge-de-l- osteoporose-la-has-publie-une-synthese-a-destination-des-professionnels-de- sante?xtmc=&xtcr=1 ,